200 related articles for article (PubMed ID: 15998581)
1. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes.
Cannons JL; Chamberlain G; Howson J; Smink LJ; Todd JA; Peterson LB; Wicker LS; Watts TH
J Autoimmun; 2005 Aug; 25(1):13-20. PubMed ID: 15998581
[TBL] [Abstract][Full Text] [Related]
2. Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region.
Irie J; Wu Y; Sass DA; Ridgway WM
Immunogenetics; 2006 Feb; 58(1):9-14. PubMed ID: 16425035
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.
Sica G; Chen L
Arch Immunol Ther Exp (Warsz); 1999; 47(5):275-9. PubMed ID: 10604232
[TBL] [Abstract][Full Text] [Related]
4. Costimulation of CD28- T lymphocytes by 4-1BB ligand.
DeBenedette MA; Shahinian A; Mak TW; Watts TH
J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967
[TBL] [Abstract][Full Text] [Related]
5. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT; Mufti GJ; Guinn BA
Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
[TBL] [Abstract][Full Text] [Related]
6. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.
Cannons JL; Hoeflich KP; Woodgett JR; Watts TH
J Immunol; 1999 Sep; 163(6):2990-8. PubMed ID: 10477561
[TBL] [Abstract][Full Text] [Related]
7. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
[TBL] [Abstract][Full Text] [Related]
8. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
Hurtado JC; Kim YJ; Kwon BS
J Immunol; 1997 Mar; 158(6):2600-9. PubMed ID: 9058792
[TBL] [Abstract][Full Text] [Related]
9. 4-1BB costimulation promotes human T cell adhesion to fibronectin.
Kim YJ; Mantel PL; June CH; Kim SH; Kwon BS
Cell Immunol; 1999 Feb; 192(1):13-23. PubMed ID: 10066342
[TBL] [Abstract][Full Text] [Related]
10. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
[TBL] [Abstract][Full Text] [Related]
11. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137.
Lyons PA; Hancock WW; Denny P; Lord CJ; Hill NJ; Armitage N; Siegmund T; Todd JA; Phillips MS; Hess JF; Chen SL; Fischer PA; Peterson LB; Wicker LS
Immunity; 2000 Jul; 13(1):107-15. PubMed ID: 10933399
[TBL] [Abstract][Full Text] [Related]
12. 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells.
Choi BK; Bae JS; Choi EM; Kang WJ; Sakaguchi S; Vinay DS; Kwon BS
J Leukoc Biol; 2004 May; 75(5):785-91. PubMed ID: 14694186
[TBL] [Abstract][Full Text] [Related]
13. Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses.
Tan JT; Ha J; Cho HR; Tucker-Burden C; Hendrix RC; Mittler RS; Pearson TC; Larsen CP
Transplantation; 2000 Jul; 70(1):175-83. PubMed ID: 10919597
[TBL] [Abstract][Full Text] [Related]
14. The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.
Kachapati K; Adams DE; Wu Y; Steward CA; Rainbow DB; Wicker LS; Mittler RS; Ridgway WM
J Immunol; 2012 Nov; 189(10):5001-15. PubMed ID: 23066155
[TBL] [Abstract][Full Text] [Related]
15. A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity.
Yoshida H; Katayose Y; Unno M; Suzuki M; Kodama H; Takemura S; Asano R; Hayashi H; Yamamoto K; Matsuno S; Kudo T
Cancer Immunol Immunother; 2003 Feb; 52(2):97-106. PubMed ID: 12594573
[TBL] [Abstract][Full Text] [Related]
16. Congenic mapping identifies a novel Idd9 subregion regulating type 1 diabetes in NOD mice.
Lin B; Ciecko AE; MacKinney E; Serreze DV; Chen YG
Immunogenetics; 2017 Mar; 69(3):193-198. PubMed ID: 27796442
[TBL] [Abstract][Full Text] [Related]
17. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
[TBL] [Abstract][Full Text] [Related]
18. Combined congenic mapping and nuclease-based gene targeting for studying allele-specific effects of Tnfrsf9 within the Idd9.3 autoimmune diabetes locus.
Forsberg MH; Foda B; Serreze DV; Chen YG
Sci Rep; 2019 Mar; 9(1):4316. PubMed ID: 30867509
[TBL] [Abstract][Full Text] [Related]
19. Biological activities of reverse signal transduction through CD137 ligand.
Schwarz H
J Leukoc Biol; 2005 Mar; 77(3):281-6. PubMed ID: 15618293
[TBL] [Abstract][Full Text] [Related]
20. Molecular and biological characterization of human 4-1BB and its ligand.
Alderson MR; Smith CA; Tough TW; Davis-Smith T; Armitage RJ; Falk B; Roux E; Baker E; Sutherland GR; Din WS
Eur J Immunol; 1994 Sep; 24(9):2219-27. PubMed ID: 8088337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
